Detalhe da pesquisa
1.
N-MYC-interacting protein enhances type II interferon signaling by inhibiting STAT1 sumoylation.
FASEB J
; 37(12): e23281, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37933920
2.
Human cytomegalovirus UL23 inhibits transcription of interferon-γ stimulated genes and blocks antiviral interferon-γ responses by interacting with human N-myc interactor protein.
PLoS Pathog
; 14(1): e1006867, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29377960
3.
Preparation and identification of polyclonal antibody against human cytomegalovirus encoding protein UL23.
Protein Expr Purif
; 161: 78-83, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31051245
4.
NCPAD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer.
Genes Environ
; 46(1): 2, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172945
5.
NSP6 inhibits the production of ACE2-containing exosomes to promote SARS-CoV-2 infectivity.
mBio
; 15(3): e0335823, 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38303107
6.
An integrative pan-cancer analysis reveals the carcinogenic effects of NCAPH in human cancer.
Math Biosci Eng
; 20(1): 76-92, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36650758
7.
The NQO1/p53/SREBP1 axis promotes hepatocellular carcinoma progression and metastasis by regulating Snail stability.
Oncogene
; 41(47): 5107-5120, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36253445
8.
Downregulation of N-myc Interactor Promotes Cervical Cancer Cells Growth by Activating Stat3 Signaling.
Cell Biochem Biophys
; 79(1): 103-111, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106998
9.
Human Cytomegalovirus UL23 Attenuates Signal Transducer and Activator of Transcription 1 Phosphorylation and Type I Interferon Response.
Front Microbiol
; 12: 692515, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34305856
10.
Generation and Application of Mouse Monoclonal Antibody Against Human Cytomegalovirus UL23.
Viral Immunol
; 33(5): 378-383, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32181702
11.
Correction: NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer.
Genes Environ
; 46(1): 6, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38347640